Molecular biology reports · 2026
Vitamin D delivered through carbon quantum dots modifies cytokine expression and migration in MCF-7 breast cancer cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Batur Lutfiye Karcioglu, Yavas Cuneyd, Kulus Firuze, Aslan Buse, Pektas Ahsen, Bilakaya Besa, Akcali Nermin, Aslan Elif Sibel, Gunen Furkan, Degim İsmail Tuncer
Аннотация
BACKGROUND: Vitamin D is a crucial regulator of immune responses and has recognized anti-proliferative effects in cancer. However, its clinical use is limited by poor solubility and bioavailability. Nanocarrier systems, such as carbon quantum dots (CQDs), may improve vitamin D delivery and activity.
METHODS: MCF-7 breast cancer cells were treated with free vitamin D or vitamin D-loaded CQDs (CQD-VitD). Cell viability was measured using the WST-8 assay; migration was assessed with a wound-healing assay; and gene expression of IL-6, IL-10, NF-κB, TNF-α, and VDR was analyzed through qRT-PCR.
RESULTS: CQD-VitD significantly increased cell viability compared to both control and free vitamin D (p < 0.01). Wound-healing assays demonstrated that CQD-VitD markedly inhibited cell migration, while free vitamin D caused moderate wound closure. Gene expression analysis showed that free vitamin D slightly decreased IL-6 and significantly suppressed IL-10 (p < 0.05). Conversely, CQD-VitD strongly upregulated IL-10 (p < 0.001) and NF-κB (p < 0.05), with TNF-α and VDR expression remaining unchanged.
CONCLUSION: CQD-based delivery of vitamin D enhances its cellular activity and selectively affects immune-related genes in breast cancer cells. Although CQD-VitD reduced migration and increased cell viability, its upregulation of IL-10 and NF-κB suggests a complex role in tumor-immune interactions. These findings highlight both the potential and the challenges of nanocarrier-mediated vitamin D delivery in breast cancer therapy. To our knowledge, this is the first study to investigate the effects of vitamin D-loaded carbon quantum dots on immune-related gene expression in breast cancer cells.
METHODS: MCF-7 breast cancer cells were treated with free vitamin D or vitamin D-loaded CQDs (CQD-VitD). Cell viability was measured using the WST-8 assay; migration was assessed with a wound-healing assay; and gene expression of IL-6, IL-10, NF-κB, TNF-α, and VDR was analyzed through qRT-PCR.
RESULTS: CQD-VitD significantly increased cell viability compared to both control and free vitamin D (p < 0.01). Wound-healing assays demonstrated that CQD-VitD markedly inhibited cell migration, while free vitamin D caused moderate wound closure. Gene expression analysis showed that free vitamin D slightly decreased IL-6 and significantly suppressed IL-10 (p < 0.05). Conversely, CQD-VitD strongly upregulated IL-10 (p < 0.001) and NF-κB (p < 0.05), with TNF-α and VDR expression remaining unchanged.
CONCLUSION: CQD-based delivery of vitamin D enhances its cellular activity and selectively affects immune-related genes in breast cancer cells. Although CQD-VitD reduced migration and increased cell viability, its upregulation of IL-10 and NF-κB suggests a complex role in tumor-immune interactions. These findings highlight both the potential and the challenges of nanocarrier-mediated vitamin D delivery in breast cancer therapy. To our knowledge, this is the first study to investigate the effects of vitamin D-loaded carbon quantum dots on immune-related gene expression in breast cancer cells.